These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15557383)

  • 1. Images in cardiovascular medicine. In-stent neointimal hyperplasia with 16-row multislice computed tomography coronary angiography.
    Mollet NR; Cademartiri F
    Circulation; 2004 Nov; 110(21):e514. PubMed ID: 15557383
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation.
    Takebayashi H; Mintz GS; Carlier SG; Kobayashi Y; Fujii K; Yasuda T; Costa RA; Moussa I; Dangas GD; Mehran R; Lansky AJ; Kreps E; Collins MB; Colombo A; Stone GW; Leon MB; Moses JW
    Circulation; 2004 Nov; 110(22):3430-4. PubMed ID: 15557367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of assessment of coronary stent patency using 16-slice computed tomography.
    Schuijf JD; Bax JJ; Jukema JW; Lamb HJ; Warda HM; Vliegen HW; de Roos A; van der Wall EE
    Am J Cardiol; 2004 Aug; 94(4):427-30. PubMed ID: 15325923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent thrombosis following the STAR technique in a complex RCA chronic total occlusion.
    Erlich I; Strauss BH; Butany J
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):708-12. PubMed ID: 17039512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and spatial relation of baseline atherosclerotic plaque burden and subsequent in-stent neointimal proliferation as determined by intravascular ultrasound.
    Hibi K; Suzuki T; Honda Y; Hayase M; Bonneau HN; Yock PG; Yeung AC; Fitzgerald PJ
    Am J Cardiol; 2002 Nov; 90(10):1164-7. PubMed ID: 12423727
    [No Abstract]   [Full Text] [Related]  

  • 6. Heterogeneity of neointimal distribution of in-stent restenosis in patients with diabetes mellitus.
    Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan A; Honda Y; Yock PG; Fitzgerald PJ
    Am J Cardiol; 2006 Feb; 97(3):340-2. PubMed ID: 16442392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gender on neointimal hyperplasia following coronary artery stenting.
    Kaneda H; Ako J; Kataoka T; Takahashi T; Terashima M; Waseda K; Miyazawa A; Hassan AH; Honda Y; Yock PG; Fitzgerald PJ
    Am J Cardiol; 2007 Feb; 99(4):491-3. PubMed ID: 17293191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-stent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-elevation myocardial infarction (STEMMI Trial).
    Jørgensen E; Ripa RS; Helqvist S; Wang Y; Johnsen HE; Grande P; Kastrup J
    Int J Cardiol; 2006 Jul; 111(1):174-7. PubMed ID: 16054717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
    Abizaid A; Lansky AJ; Fitzgerald PJ; Tanajura LF; Feres F; Staico R; Mattos L; Abizaid A; Chaves A; Centemero M; Sousa AG; Sousa JE; Zaugg MJ; Schwartz LB
    Am J Cardiol; 2007 May; 99(10):1403-8. PubMed ID: 17493469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of bone-marrow- and neural-crest-derived cells in intimal hyperplasia at the time of clinical in-stent restenosis.
    Skowasch D; Jabs A; Andrié R; Dinkelbach S; Lüderitz B; Bauriedel G
    Cardiovasc Res; 2003 Dec; 60(3):684-91. PubMed ID: 14659814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
    Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
    Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive angiographic evaluation of coronary stents with multi-slice spiral computed tomography.
    Nieman K; Cademartiri F; Raaijmakers R; Pattynama P; de Feyter P
    Herz; 2003 Mar; 28(2):136-42. PubMed ID: 12669227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-stent restenosis and multislice computed tomography: is the method ready to start?
    Martuscelli E; Razzini C; D'Eliseo A; Di Luozzo M; Mauro B; Romeo F
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):377-80. PubMed ID: 17443107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A paclitaxel-eluting stent for the prevention of coronary restenosis.
    Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
    N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional stenting promotes intimal proliferation and compromises the results of intravascular radiation therapy: an intravascular ultrasound study.
    Cheneau E; Wu Z; Leborgne L; Ajani AE; Weissman N; Pichard AD; Satler LF; Kent KM; Mintz G; Waksman R
    Am Heart J; 2003 Jul; 146(1):142-5. PubMed ID: 12851623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of native coronary artery in-stent recurrence rates with longer versus shorter narrowings.
    Ahmed JM; Mintz GS; Waksman R; Pichard AD; Satler LF; Kent KM; Weissman NJ
    Am J Cardiol; 2002 Aug; 90(4):422-5. PubMed ID: 12161236
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial.
    Hausleiter J; Kastrati A; Mehilli J; Vogeser M; Zohlnhöfer D; Schühlen H; Goos C; Pache J; Dotzer F; Pogatsa-Murray G; Dirschinger J; Heemann U; Schömig A;
    Circulation; 2004 Aug; 110(7):790-5. PubMed ID: 15302787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal hyperplasia and late pathologic remodeling in a porcine coronary stent model.
    De Scheerder I ; Wang K; Zhou XR; Verbeken E; Ping QB; Yanming H; Jianhua H; Szilard M; Van de Werf F
    J Invasive Cardiol; 1999 Jan; 11(1):9-12. PubMed ID: 10745430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study.
    Nunes GL; Abizaid AC; Theodoro MP; Brito FS; Caixeta A; da Silva LF; Mazzotti NG; Belló-Klein A; Clausell N
    Am Heart J; 2006 Nov; 152(5):914.e1-7. PubMed ID: 17070157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.